Expert NetworkExpert InterviewTGTX

Slingshot members are talking to an expert! The topic is:

Discussing the potential of CD20 as class in treating Multiple Sclerosis with a focus on BRIUMVI, Kesimpta, and Ocrevus

Executed on:May 11, 2023 2:30 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: WUSTL
  • Professor of Neurology and Director of Multiple Sclerosis Clinic at Washington University School of Medicine, St. Louis.
  • Currently treats 500 patients with Multiple Sclerosis (3000 MS patients at center).
  • Research focuses on the use of MRI sequences to correlate optic nerves, brain and spinal imaging with clinical diseases and to predict long-term outcome of patients with Multiple Sclerosis.

Interview Goal

This conversation will focus on the multiple sclerosis treatment landscape. We will dig into CD20 agents and get an expert's view on how this class performs in treatment.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.